We are live on ! Find out more
CERE

Cerevel Therapeutics Holdings, Inc. Common Stock
CERE

Delisted

CERE was delisted on the 31st of July, 2024.

Back to rankings

2 hedge funds and large institutions have $20.7K invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 228 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

99% less funds holding

Funds holding: 231 → 2 (-229)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $6.42B → $20.7K (-$6.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 228

Holders
2
Holders Change
-229
Holders Change %
-99.13%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
228
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BTI
Blue Trust Inc
Georgia
+$297

Top Sellers

Rank Fund Capital Flow
1
BCI
Bain Capital Investors
Massachusetts
-$2.69B
2
PA
Perceptive Advisors
New York
-$441M
3
ACA
Avoro Capital Advisors
New York
-$308M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$293M
5
BlackRock
BlackRock
New York
-$146M
Name Holding Trade Value Shares
Change 		Change in
Stake
FLSM
51
Frazier Life Sciences Management
California
– -$16.1M -393,000 Closed
HF
52
HRT Financial
New York
– -$15.4M -377,431 Closed
State of Wisconsin Investment Board
53
State of Wisconsin Investment Board
Wisconsin
– -$15M -367,973 Closed
Renaissance Technologies
54
Renaissance Technologies
New York
– -$14.8M -361,400 Closed
GF
55
Gabelli Funds
New York
– -$14.2M -347,624 Closed
Bank of America
56
Bank of America
North Carolina
– -$13.8M -338,455 Closed
Man Group
57
Man Group
United Kingdom
– -$13.8M -337,271 Closed
WP
58
Woodline Partners
California
– -$13.7M -335,500 Closed
Morgan Stanley
59
Morgan Stanley
New York
– -$13.5M -330,728 Closed
TC
60
Trium Capital
United Kingdom
– -$13M -317,731 Closed
Janus Henderson Group
61
Janus Henderson Group
United Kingdom
– -$12M -293,385 Closed
UBS Group
62
UBS Group
Switzerland
– -$11.9M -291,457 Closed
SAM
63
Stansberry Asset Management
Texas
– -$11.5M -281,694 Closed
PCM
64
Prelude Capital Management
New York
– -$11.1M -270,572 Closed
Jane Street
65
Jane Street
New York
– -$11M -269,948 Closed
DKCM
66
Davidson Kempner Capital Management
New York
– -$10.6M -260,399 Closed
FTCM
67
First Trust Capital Management
Illinois
– -$10.3M -250,985 Closed
PMAM
68
Picton Mahoney Asset Management
Ontario, Canada
– -$10.2M -250,000 Closed
Bank of New York Mellon
69
Bank of New York Mellon
New York
– -$10.2M -249,362 Closed
RAM
70
Readystate Asset Management
Illinois
– -$10.1M -248,027 Closed
Verition Fund Management
71
Verition Fund Management
Connecticut
– -$8.37M -204,808 Closed
AC
72
Armistice Capital
New York
– -$8.25M -201,743 Closed
GL
73
Governors Lane
New York
– -$7.88M -192,700 Closed
GLAM
74
Gardner Lewis Asset Management
Pennsylvania
– -$7.86M -192,150 Closed
Rafferty Asset Management
75
Rafferty Asset Management
New York
– -$7.49M -183,293 Closed
1 2
3
4 5

CERE Hedge Fund Activity: Q3 2024 in Review

2 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) for Q3 2024, worth a combined $20.7K — down 100% from $6.42B a quarter earlier.

Sellers outnumbered buyers: 228 funds closed out of CERE and 0 opened new positions — a net loss of 228 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Blue Trust Inc, adding an estimated $297. The largest seller was Bain Capital Investors, exiting entirely with an estimated $2.69B sold.

  • 2 institutional investors held Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) as of Q3 2024, down from 231 in Q2 2024.
  • Funds reported $20.7K of Cerevel Therapeutics Holdings, Inc. Common Stock stock for Q3 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Cerevel Therapeutics Holdings, Inc. Common Stock positions in Q3 2024 and 228 closed out, a net change of -228 holders.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock buyer in Q3 2024 was Blue Trust Inc, an estimated $297 added.
  • The largest Cerevel Therapeutics Holdings, Inc. Common Stock seller in Q3 2024 was Bain Capital Investors, an estimated $2.69B sold.

Based on aggregated 13F filings for Q3 2024.